Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Melanoma 18Uveal Melanoma 4Prostatic Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Burkitt Lymphoma 3Waldenstrom Macroglobulinemia 2Sarcoma 2Salivary Gland Neoplasms 2Recurrent Squamous Cell Lung Carcinoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm Metastasis 2Myelodysplastic Syndromes 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Acute 2Leukemia, Hairy Cell 2Leukemia, Biphenotypic, Acute 2Intraocular Lymphoma 2Hodgkin Disease 2Brain Neoplasms 2Anus Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1

Interventions

Zoledronic Acid 2Vincristine 2Temozolomide 2Radiosurgery 2Magnetic Resonance Spectroscopy 2Irinotecan 2Doxorubicin 2Cyclophosphamide 2selinexor 1saracatinib 1samarium Sm-153 lexidronam 1robatumumab 1pembrolizumab 1pegfilgrastim 1angiotensin I (1-7) 1Transcranial Direct Current Stimulation 1Tranexamic Acid 1Sunitinib 1Standard of Care 1Sodium Pertechnetate Tc 99m 1Sodium Chloride 1Samarium 1Radiation 1Proton Therapy 1Pregabalin 1Practice Guidelines as Topic 1Plicamycin 1Palliative Care 1Nivolumab 1Neutrons 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Bone Neoplasms × CTLA-4 Antigen × Clear all
NCT02500797 2023-10-17

Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Completed
164 enrolled 22 charts
Sarcoma

Bone Neoplasms, Liposarcoma, Sarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡